- Previous Close
1.3020 - Open
1.3100 - Bid 1.2960 x --
- Ask 1.3000 x --
- Day's Range
1.2740 - 1.3220 - 52 Week Range
1.1600 - 4.7700 - Volume
77,387 - Avg. Volume
278,623 - Market Cap (intraday)
329.408M - Beta (5Y Monthly) 1.65
- PE Ratio (TTM)
-- - EPS (TTM)
-0.2400 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
BrainCool AB (publ), a medical device company, together with its subsidiaries, engages in the development, marketing, and sale of medical cooling systems for the healthcare sector in Sweden. The company offers BrainCool system, a system to monitors and controls patient's temperature to anatomical zones for head/neck, thighs, and torso. It also offers RhinoChill system, a portable and battery-powered cooling product to spray liquid coolant for patient's nostrils with a catheter, as well as provides Cooral system provides medical professionals an easy way to reduce the risk of oral mucositis; and IQool system, a single-use cooling system used as silicone cooling pads for patient's care. In addition, the company provides products for medical cooling treatments for diseases, including stroke, cardiac arrest, neurological fever, chemotherapy, and oral mucositis. BrainCool AB (publ) was incorporated in 2010 and is based in Lund, Sweden.
braincoolinc.comRecent News: BRAIN.ST
View MorePerformance Overview: BRAIN.ST
Trailing total returns as of 1/17/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: BRAIN.ST
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: BRAIN.ST
View MoreValuation Measures
Market Cap
329.41M
Enterprise Value
313.43M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
8.79
Price/Book (mrq)
2.14
Enterprise Value/Revenue
8.36
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-141.57%
Return on Assets (ttm)
-19.50%
Return on Equity (ttm)
-39.83%
Revenue (ttm)
40.67M
Net Income Avi to Common (ttm)
-57.58M
Diluted EPS (ttm)
-0.2400
Balance Sheet and Cash Flow
Total Cash (mrq)
41.27M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
-50.66M